Literature DB >> 24587649

Diabetes and gastric cancer: the potential links.

Chin-Hsiao Tseng1, Farn-Hsuan Tseng1.   

Abstract

This article reviews the epidemiological evidence linking diabetes and gastric cancer and discusses some of the potential mechanisms, confounders and biases in the evaluation of such an association. Findings from four meta-analyses published from 2011 to 2013 suggest a positive link, which may be more remarkable in females and in the Asian populations. Putative mechanisms may involve shared risk factors, hyperglycemia, Helicobacter pylori (H. pylori) infection, high salt intake, medications and comorbidities. Diabetes may increase the risk of gastric cancer through shared risk factors including obesity, insulin resistance, hyperinsulinemia and smoking. Hyperglycemia, even before the clinical diagnosis of diabetes, may predict gastric cancer in some epidemiological studies, which is supported by in vitro, and in vivo studies. Patients with diabetes may also have a higher risk of gastric cancer through the higher infection rate, lower eradication rate and higher reinfection rate of H. pylori. High salt intake can act synergistically with H. pylori infection in the induction of gastric cancer. Whether a higher risk of gastric cancer in patients with diabetes may be ascribed to a higher intake of salt due to the loss of taste sensation awaits further investigation. The use of medications such as insulin, metformin, sulfonylureas, aspirin, statins and antibiotics may also influence the risk of gastric cancer, but most of them have not been extensively studied. Comorbidities may affect the development of gastric cancer through the use of medications and changes in lifestyle, dietary intake, and the metabolism of drugs. Finally, a potential detection bias related to gastrointestinal symptoms more commonly seen in patients with diabetes and with multiple comorbidities should be pointed out. Taking into account the inconsistent findings and the potential confounders and detection bias in previous epidemiological studies, it is expected that there are still more to be explored for the clarification of the association between diabetes and gastric cancer.

Entities:  

Keywords:  Diabetes mellitus; Epidemiology; Gastric cancer; Literature review; Meta-analysis

Mesh:

Substances:

Year:  2014        PMID: 24587649      PMCID: PMC3930970          DOI: 10.3748/wjg.v20.i7.1701

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  123 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Evaluation of the role of vascular endothelial growth factor in diabetic retinopathy.

Authors:  Reda A Mahdy; Waled M Nada
Journal:  Ophthalmic Res       Date:  2010-08-19       Impact factor: 2.892

3.  Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers.

Authors:  Shih-Wen Lin; Neal D Freedman; Albert R Hollenbeck; Arthur Schatzkin; Christian C Abnet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-17       Impact factor: 4.254

4.  Diabetes mellitus and risk of colorectal cancer: a meta-analysis.

Authors:  Susanna C Larsson; Nicola Orsini; Alicja Wolk
Journal:  J Natl Cancer Inst       Date:  2005-11-16       Impact factor: 13.506

5.  Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells.

Authors:  H K Yi; P H Hwang; D H Yang; C W Kang; D Y Lee
Journal:  Eur J Cancer       Date:  2001-11       Impact factor: 9.162

6.  Type 2 diabetes, smoking, insulin use, and mortality from hepatocellular carcinoma: a 12-year follow-up of a national cohort in Taiwan.

Authors:  Chin-Hsiao Tseng
Journal:  Hepatol Int       Date:  2012-10-06       Impact factor: 6.047

7.  Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection.

Authors:  Sherifa Ahmed Hamed; Nabila F Amine; Ghada M Galal; Shaaban R Helal; Lubna M Tag El-Din; Ola A Shawky; Eman A Ahmed; Mohamed S Abdel Rahman
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Mar-Apr       Impact factor: 2.136

Review 8.  Advanced research on risk factors of type 2 diabetes.

Authors:  Yufang Bi; Tiange Wang; Min Xu; Yu Xu; Mian Li; Jieli Lu; Xiaolin Zhu; Guang Ning
Journal:  Diabetes Metab Res Rev       Date:  2012-12       Impact factor: 4.876

Review 9.  Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer.

Authors:  Masaru Katoh
Journal:  Cancer Biol Ther       Date:  2007-03-26       Impact factor: 4.742

10.  Association between Habitual Dietary Salt Intake and Risk of Gastric Cancer: A Systematic Review of Observational Studies.

Authors:  Sheng Ge; Xiaohui Feng; Li Shen; Zhanying Wei; Qiankun Zhu; Juan Sun
Journal:  Gastroenterol Res Pract       Date:  2012-10-22       Impact factor: 2.260

View more
  34 in total

1.  Association between dietary carbohydrate intake, glycemic index and glycemic load, and risk of gastric cancer.

Authors:  Yao Ye; Yihua Wu; Jinming Xu; Kefeng Ding; Xiaoyun Shan; Dajing Xia
Journal:  Eur J Nutr       Date:  2016-02-12       Impact factor: 5.614

2.  Association between Adherence to the Mediterranean Diet and Risk of Type 2 Diabetes: An Updated Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.

Authors:  Peyman Sarsangi; Amin Salehi-Abargouei; Soraiya Ebrahimpour-Koujan; Ahmad Esmaillzadeh
Journal:  Adv Nutr       Date:  2022-10-02       Impact factor: 11.567

Review 3.  Obesity and related risk factors in gastric cardia adenocarcinoma.

Authors:  Sidney Olefson; Steven F Moss
Journal:  Gastric Cancer       Date:  2014-09-11       Impact factor: 7.370

4.  Clinical course of diabetes after gastrectomy according to type of reconstruction in patients with concurrent gastric cancer and type 2 diabetes.

Authors:  Zhenxin Zhu; Xiaodong Shan; Yajun Cheng; Jiapeng Xu; Hongbing Fu; Weimin Wang; Ronglin Yan; Qingping Cai
Journal:  Obes Surg       Date:  2015-04       Impact factor: 4.129

5.  Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients.

Authors:  Kosuke Sakitani; Yoshihiro Hirata; Nobumi Suzuki; Satoki Shichijo; Ayako Yanai; Takako Serizawa; Kei Sakamoto; Masao Akanuma; Shin Maeda; Yutaka Yamaji; Yasuhiko Iwamoto; Shoji Kawazu; Kazuhiko Koike
Journal:  BMC Gastroenterol       Date:  2015-10-21       Impact factor: 3.067

6.  Incidence and Mortality Risks of Cancer in Patients with Type 2 Diabetes: A Retrospective Study in Shanghai, China.

Authors:  Yunjuan Gu; Xuhong Hou; Ying Zheng; Chunfang Wang; Lei Zhang; Jie Li; Zhezhou Huang; Ming Han; Yuqian Bao; Weijian Zhong; Weiping Jia; Shiwei Cui
Journal:  Int J Environ Res Public Health       Date:  2016-06-03       Impact factor: 3.390

7.  Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.

Authors:  Chin-Hsiao Tseng
Journal:  Aging (Albany NY)       Date:  2016-08       Impact factor: 5.682

8.  Association of diabetes and cancer mortality in American Indians: the Strong Heart Study.

Authors:  Lyle G Best; Esther García-Esquinas; Jeun-Liang Yeh; Fawn Yeh; Ying Zhang; Elisa T Lee; Barbara V Howard; John H Farley; Thomas K Welty; Dorothy A Rhoades; Everett R Rhoades; Jason G Umans; Ana Navas-Acien
Journal:  Cancer Causes Control       Date:  2015-08-07       Impact factor: 2.506

9.  Lnc-SGK1 induced by Helicobacter pylori infection and highsalt diet promote Th2 and Th17 differentiation in human gastric cancer by SGK1/Jun B signaling.

Authors:  Yongliang Yao; Qingbo Jiang; Lixing Jiang; Jianhong Wu; Qinghui Zhang; Jianjun Wang; Huang Feng; Panpan Zang
Journal:  Oncotarget       Date:  2016-04-12

10.  Association between Tooth Loss and Gastric Cancer: A Meta-Analysis of Observational Studies.

Authors:  Xin-Hai Yin; Ya-Dong Wang; Hong Luo; Ke Zhao; Guang-Lei Huang; Si-Yang Luo; Ju-Xiang Peng; Ju-Kun Song
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.